AQR Capital Management - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$672,411
+129.0%
501,799
+205.9%
0.00%0.0%
Q2 2023$293,628
-6.2%
164,038
+103.7%
0.00%0.0%
Q1 2023$313,196
+49.4%
80,513
+30.6%
0.00%
Q4 2022$209,600
-65.9%
61,647
-45.3%
0.00%
-100.0%
Q3 2022$615,000
+502.9%
112,676
+398.1%
0.00%
Q2 2022$102,000
-50.2%
22,622
-18.7%
0.00%
Q1 2022$205,000
-84.0%
27,830
-68.3%
0.00%
-100.0%
Q3 2020$1,281,000
-25.8%
87,761
-3.7%
0.00%
-33.3%
Q2 2020$1,726,000
+50.5%
91,121
+52.6%
0.00%
+50.0%
Q1 2020$1,147,000
+416.7%
59,714
+415.0%
0.00%
Q4 2019$222,000
-7.5%
11,594
-54.7%
0.00%
Q4 2018$240,000
-54.2%
25,596
-16.8%
0.00%
-100.0%
Q3 2018$524,000
+61.2%
30,767
+60.6%
0.00%
Q2 2018$325,000
-25.3%
19,153
+34.9%
0.00%
-100.0%
Q1 2015$435,000
-4.0%
14,200
+17.4%
0.00%0.0%
Q4 2014$453,00012,1000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders